Multimodal oculomotor assessment reveals prodromal markers of Parkinson’s disease in non-manifesting LRRK2 G2019S mutation carriers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Multimodal oculomotor assessment reveals prodromal markers of Parkinson’s disease in non-manifesting LRRK2 G2019S mutation carriers ; volume:10 ; number:1 ; day:19 ; month:12 ; year:2024 ; pages:1-13 ; date:12.2024
npj Parkinson's Disease ; 10, Heft 1 (19.12.2024), 1-13, 12.2024
- Creator
-
Riek, Heidi C.
Visanji, Naomi P.
Pitigoi, Isabell C.
Di Luca, Daniel G.
Armengou-Garcia, Laura
Ahmed, Nazish
Perkins, Julia E.
Brien, Donald C.
Huang, Jeff
Coe, Brian C.
Huang, Jana
Ghate, Taneera
Lang, Anthony E.
Marras, Connie
Munoz, Douglas P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-024-00840-w
- URN
-
urn:nbn:de:101:1-2503020635588.139615277138
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Riek, Heidi C.
- Visanji, Naomi P.
- Pitigoi, Isabell C.
- Di Luca, Daniel G.
- Armengou-Garcia, Laura
- Ahmed, Nazish
- Perkins, Julia E.
- Brien, Donald C.
- Huang, Jeff
- Coe, Brian C.
- Huang, Jana
- Ghate, Taneera
- Lang, Anthony E.
- Marras, Connie
- Munoz, Douglas P.
- SpringerLink (Online service)
Other Objects (12)
Sex-dependent interactions between prodromal intestinal inflammation and LRRK2 G2019S in mice promote endophenotypes of Parkinson’s disease
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
A look back at the prodromal findings in Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Sex-dependent interactions between prodromal intestinal inflammation and LRRK2 G2019S in mice promote endophenotypes of Parkinson’s disease
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
A look back at the prodromal findings in Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Sex-dependent interactions between prodromal intestinal inflammation and LRRK2 G2019S in mice promote endophenotypes of Parkinson’s disease
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
A look back at the prodromal findings in Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2